Previous Close | 100.73 |
Open | 101.02 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 100.62 - 101.78 |
52 Week Range | 93.01 - 128.46 |
Volume | 24,696 |
Avg. Volume | 90,242 |
Market Cap | 4.055B |
Beta | 0.40 |
PE Ratio (TTM) | 19.64 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Taro Pharmaceutical Industries Ltd NYSE:TARO
Taro Pharmaceutical Industries Ltd (NYSE:TARO), a pharmaceuticals company based in Israel, received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More...
Taro Pharmaceutical Industries Ltd (NYSE:TARO) is trading with a trailing P/E of 19.4x, which is lower than the industry average of 22x. While TARO might seem like an attractive stockRead More...
Taro Pharmaceutical Industries Ltd NYSE:TARO
Increase in profitability and industry-beating performance can be essential considerations in a stock for some investors. In this article, I will take a look at Taro Pharmaceutical Industries Ltd’s (NYSE:TARO)Read More...
Short interest is low for TARO with fewer than 5% of shares on loan. The net inflows of $2.08 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
Taro Pharmaceutical Industries Ltd NYSE:TARO
The Haifa Bay, Israel-based company said it had profit of 45 cents per share. Earnings, adjusted for pretax expenses and to account for discontinued operations, came to $1.37 per share. The drug maker ...
Taro Pharmaceutical Industries Ltd (NYSE:TARO), a pharmaceuticals company based in Israel, received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More...
Taro Pharmaceutical Industries Ltd (NYSE:TARO) outperformed the Pharmaceuticals industry on the basis of its ROE – producing a higher 16.01% relative to the peer average of 11.92% over the pastRead More...
Short interest is low for TARO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Guru invests in advertising, auto parts, pharmaceutical and communication equipment companies
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
Q2 2018 Taro Pharmaceutical Industries Ltd Earnings Call
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Short interest is low for TARO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $1.59 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
Taro Pharmaceutical Industries shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
The Haifa Bay, Israel-based company said it had profit of $1.30 per share. The drug maker posted revenue of $169.9 million in the period. Taro shares have climbed almost 5 percent since the beginning of ...
Short interest is low for TARO with fewer than 5% of shares on loan. The net inflows of $1.71 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)